Selectis Health (GBCS) Net Income towards Common Stockholders (2010 - 2026)

Selectis Health has reported Net Income towards Common Stockholders for 16 years, with the latest figure at -$811621.0 in Q4 2025.

• Quarterly Net Income towards Common Stockholders fell 40.79% year-over-year to -$811621.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.1 million (up 56.95% YoY) and the FY2025 annual result came in at -$1.1 million, up 56.95% from the prior year.
• Net Income towards Common Stockholders declined to -$811621.0 in Q4 2025 per GBCS's latest filing, from $744865.0 in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $4.0 million in Q1 2023 and troughed at -$3.6 million in Q4 2023.
• A 5-year average of -$586209.3 and a median of -$678624.5 in 2021 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders sank 1550.51% in 2022, then jumped 1656.91% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at -$1.8 million in 2021, then dropped by 23.87% to -$2.2 million in 2022, then slumped by 65.5% to -$3.6 million in 2023, then surged by 84.17% to -$576463.0 in 2024, then tumbled by 40.79% to -$811621.0 in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$811621.0, $744865.0, and -$315527.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.